Ubiquitin Proteasome System Role in Diabetes-Induced Cardiomyopathy

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Metabolic Diseases

Background:

• Type 2 diabetes mellitus (T2DM) is associated with significant cardiovascular complications.
• The ubiquitin proteasome system (UPS) plays a critical role in protein homeostasis and cellular function.
• Dysregulation of the UPS has been implicated in various pathological conditions, including diabetes.

Purpose of the Study:

• To investigate cardiac ubiquitin proteasome system (UPS) modifications in a mouse model of type 2 diabetes mellitus (T2DM).
• To explore the relationship between these UPS alterations and the development of diabetic heart complications.

Main Methods:

• Utilized db/db mice as a model for T2DM and compared their heart tissues with wild-type (WT) mice.
• Employed RNA sequencing, quantitative real-time PCR (qRT-PCR), and protein analysis to assess gene and protein expression.
• Focused on key UPS components, including deubiquitinating enzymes, proteasome subunits, and E3 ligases.

Main Results:

• Identified a distinct gene expression profile in diabetic mouse hearts, with decreased nppb and increased Myh7 mRNA levels, suggesting cardiac dysfunction.
• Observed down-regulation of USP18, PSMB8, and PSMB9 mRNA (UPS components) and up-regulation of RNF167 mRNA (E3 ligase) in db/db mice.
• Confirmed down-regulation of LMP2 and LMP7 proteins and elevated RNF167 protein levels in diabetic mouse hearts.

Conclusions:

• Cardiac UPS dysregulation, characterized by reduced proteasome activity (LMP2, LMP7) and increased E3 ligase (RNF167) expression, is evident in T2DM mouse models.
• These UPS imbalances may contribute to the cardiac deterioration observed in diabetes.
• Further research into the interplay between UPS, autophagy, and diabetic heart disease is warranted for potential therapeutic strategies.